Page last updated: 2024-10-30

metformin and Leukemia, Lymphoid

metformin has been researched along with Leukemia, Lymphoid in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vakana, E1
Altman, JK1
Glaser, H1
Donato, NJ1
Platanias, LC1
Levy, JM1
Stoll, C1
Amar, U1
Thierry, R1
Segura, N1
Bouaziz, M1

Other Studies

2 other studies available for metformin and Leukemia, Lymphoid

ArticleYear
Antileukemic effects of AMPK activators on BCR-ABL-expressing cells.
    Blood, 2011, Dec-08, Volume: 118, Issue:24

    Topics: Amino Acid Substitution; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Antineopl

2011
[Exogenous steroid diabetes in a leukemic boy. Study of insulin and GH blood levels].
    Archives francaises de pediatrie, 1973, Volume: 30, Issue:10

    Topics: Blood Glucose; Child; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucose Tolerance Test;

1973